
Journal of International Oncology ›› 2026, Vol. 53 ›› Issue (2): 111-114.doi: 10.3760/cma.j.cn371439-20250612-00017
• Review • Previous Articles Next Articles
Yang Rui, Guo Xinwei(
), Liu Yangchen
Received:2025-06-12
Online:2026-02-08
Published:2026-01-29
Contact:
Guo Xinwei
E-mail:guoxinwei66688@163.com
Supported by:Yang Rui, Guo Xinwei, Liu Yangchen. Research progress on the impact of fibrinogen/prealbumin ratio for the prediction of prognosis of digestive system tumors[J]. Journal of International Oncology, 2026, 53(2): 111-114.
| [1] | Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2022[J]. CA Cancer J Clin, 2022, 72(1): 7-33. DOI: 10.3322/caac.21708. |
| [2] | 江山, 徐阳涛, 刘昕, 等. 基线外周血炎性标志物对免疫治疗联合靶向治疗中晚期肝细胞癌患者预后的预测价值[J]. 国际肿瘤学杂志, 2023, 50(10): 600-607. DOI: 10.3760/cma.j.cn371439-20230704-00114. |
| [3] | Zhao H, Wu L, Yan G, et al. Inflammation and tumor progression: signaling pathways and targeted intervention[J]. Signal Transduct Target Ther, 2021, 6(1): 263. DOI: 10.1038/s41392-021-00658-5. |
| [4] |
Liu X, Shi B. Progress in research on the role of fibrinogen in lung cancer[J]. Open Life Sci, 2020, 15(1): 326-330. DOI: 10.1515/biol-2020-0035.
pmid: 33817221 |
| [5] |
Tupikowski K, Jaobsche-Policht U, Bittner J, et al. The influences of selected clotting and fibrinolysis factors on survival of patients with kidney tumors—a prospective study[J]. Arch Med Sci, 2023, 19(4): 1003-1010. DOI: 10.5114/aoms/128845.
pmid: 37560740 |
| [6] | Zhang X, Zhao W, Chen X, et al. Combining the fibrinogen-to-pre-albumin ratio and prognostic nutritional index (FPR-PNI) predicts the survival in elderly gastric cancer patients after gastrectomy[J]. Onco Targets Ther, 2020, 13: 8845-8859. DOI: 10.2147/OTT.S264199. |
| [7] | Li B, Deng H, Zhou Z, et al. The prognostic value of the fibrinogen to pre-albumin ratio in malignant tumors of the digestive system: a systematic review and meta-analysis[J]. Cancer Cell Int, 2022, 22(1): 22. DOI: 10.1186/s12935-022-02445-w. |
| [8] | Zhang L, Wang Z, Xiao J, et al. Prognostic value of fibrinogen-to-albumin ratio in patients with gastric cancer receiving first-line chemotherapy[J]. Oncol Lett, 2020, 20(4): 10. DOI: 10.3892/ol.2020.11871. |
| [9] |
Deng S, Fan Z, Xia H, et al. Fibrinogen/albumin ratio as a promising marker for predicting survival in pancreatic neuroendocrine neoplasms[J]. Cancer Manag Res, 2021, 13: 107-115. DOI: 10.2147/CMAR.S275173.
pmid: 33447083 |
| [10] |
Feng JF, Wang L, Jiang YH, et al. A novel prognostic index in patients with resectable esophageal squamous cell carcinoma: fibrinogen/prealbumin ratio[J]. Rev Invest Clin, 2020, 72(1): 46-54. DOI: 10.24875/RIC.19003184.
pmid: 32132740 |
| [11] |
Li H, Sun Y, Wang C, et al. Prognostic value of fibrinogen to prealbumin ratio (FPR) in resectable gastric cancer[J]. J Inflamm Res, 2024, 17: 1325-1335. DOI: 10.2147/JIR.S440832.
pmid: 38434582 |
| [12] |
Zhang J, Li SQ, Liao ZH, et al. Prognostic value of a novel FPR biomarker in patients with surgical stage Ⅱ and Ⅲ gastric cancer[J]. Oncotarget, 2017, 8(43): 75195-75205. DOI: 10.18632/oncotarget.20661
pmid: 29088857 |
| [13] | Tang S, Lin L, Cheng J, et al. The prognostic value of preoperative fibrinogen-to-prealbumin ratio and a novel FFC score in patients with resectable gastric cancer[J]. BMC Cancer, 2020, 20(1): 382. DOI: 10.1186/s12885-020-06866-6. |
| [14] | Yan H, Liu T, Yu R, et al. The role of preoperative FPR and FAR in prognostic evaluation of stages Ⅱ and Ⅲ radical colorectal cancer: a single-center retrospective study[J]. Medicine (Baltimore), 2024, 103(20): e38145. DOI: 10.1097/MD.0000000000038145. |
| [15] | Ying HQ, Sun F, Liao YC, et al. The value of circulating fibrinogen-to-pre-albumin ratio in predicting survival and benefit from chemotherapy in colorectal cancer[J]. Ther Adv Med Oncol, 2021, 13: 17588359211022886. DOI: 10.1177/17588359211022886. |
| [16] |
Chen C, Liu Y, Han P, et al. Research progress of preoperative FPR, FAR or AFR in patients with colorectal cancer[J]. Cancer Manag Res, 2021, 13: 1791-1801. DOI: 10.2147/CMAR.S292605.
pmid: 33654428 |
| [17] |
Yan H, Chen S, Qiong Y, et al. Preoperative prealbumin-to-fibrinogen ratio to predict survival outcomes in hepatocellular carcinoma patients after hepatic resection[J]. J Med Biochem, 2022, 41(3): 290-298. DOI: 10.5937/jomb0-32980.
pmid: 36042905 |
| [18] |
Shen Y, Xu Y, Wei J, et al. The prognostic role of circulating FPR before operation in patients with BCLC A-C hepatocellular carcinoma: a retrospective cohort study[J]. J Hepatocell Carcinoma, 2022, 9: 467-476. DOI: 10.2147/JHC.S369168.
pmid: 35669908 |
| [19] | Li C, Fan Z, Guo W, et al. Fibrinogen-to-prealbumin ratio: a new prognostic marker of resectable pancreatic cancer[J]. Front Oncol, 2023, 13: 1149942. DOI: 10.3389/fonc.2023.1149942. |
| [20] | Chang S, Zou Y, Huang J, et al. Fibrinogen to pre-albumin ratio is an independent prognostic index for patients with pancreatic ductal adenocarcinoma after radical resection[J]. World J Surg Oncol, 2024, 22(1): 284. DOI: 10.1186/s12957-024-03524-0. |
| [21] | Gu Y, Hua Q, Li Z, et al. Diagnostic value of combining preoperative inflammatory markers ratios with CA199 for patients with early-stage pancreatic cancer[J]. BMC Cancer, 2023, 23(1): 227. DOI: 10.1186/s12885-023-10653-4. |
| [22] |
Zhang Y, Liu N, Liu C, et al. High fibrinogen and platelets correlate with poor survival in gastric cancer patients[J]. Ann Clin Lab Sci, 2020, 50(4): 457-462.
pmid: 32826241 |
| [23] |
Milaniuk A, Drabko K, Chojęta A. Role of albumin and prealbumin in assessing nutritional status and predicting increased risk of infectious complications during childhood cancer treatment[J]. Acta Biochim Pol, 2024, 71: 13693. DOI: 10.3389/abp.2024.13693.
pmid: 39619813 |
| [24] | Wu X, Yu X, Chen C, et al. Fibrinogen and tumors[J]. Front Oncol, 2024, 14: 1393599. DOI: 10.3389/fonc.2024.1393599. |
| [25] | Zhang Y, Li Z, Zhang J, et al. Fibrinogen: a new player and target on the formation of pre-metastatic niche in tumor metastasis[J]. Crit Rev Oncol Hematol, 2025, 207: 104625. DOI: 10.1016/j.critrevonc.2025.104625. |
| [26] | Matsui R, Ida S, Ri M, et al. Impact of preoperative prealbumin levels on long-term prognosis in patients with gastric cancer after gastrectomy: a retrospective cohort study[J]. Gastric Cancer, 2024, 27(3): 611-621. DOI: 10.1007/s10120-024-01472-y. |
| [27] | Chiang HC, Lin MY, Lin FC, et al. Transferrin and prealbumin identify esophageal cancer patients with malnutrition and poor prognosis in patients with normal albuminemia: a cohort study[J]. Nutr Cancer, 2022, 74(10): 3546-3555. DOI: 10.1080/01635581.2022.2079687. |
| [28] | Nanashima A, Hiyoshi M, Imamura N, et al. Preoperative prognostic nutritional index is a significant predictive factor for posthepatectomy bile leakage[J]. Ann Hepatobiliary Pancreat Surg, 2021, 25(4): 477-484. DOI: 10.14701/ahbps.2021.25.4.477. |
| [29] | Liu B, Qian J, Zhou Y, et al. Prognostic assessment of colorectal cancer patients after laparoscopic surgery: a comprehensive evaluation of the Glasgow prognostic score and fibrinogen-to-prealbumin ratio[J]. Med Sci Monit, 2024, 30: e942658. DOI: 10.12659/MSM.942658. |
| [1] | Qiu Kexin, Li Mengzhen, Guo Haoran, Fan Mengsi, Yan Li. Prognostic analysis of different surgical approaches in elderly patients with advanced ovarian cancer [J]. Journal of International Oncology, 2025, 52(9): 576-582. |
| [2] | Liu Mei, Hu Yuchong, Li Fengtong, Chao Lemen, Liu Meng, Kang Linlin. Mechanism of action of SHCBP1 in malignant tumors and progress in clinical research [J]. Journal of International Oncology, 2025, 52(9): 583-586. |
| [3] | Lu Bing, Xiong Siyu, Jiang Wenhong, Yu Tingting. Progress in the study of fructose-bisphosphate aldolase A in lung cancer [J]. Journal of International Oncology, 2025, 52(4): 242-245. |
| [4] | Yang Shengjun, Ren Jiang, Yang Dan, Long Yu, Shang Qunxian. Expression levels and clinical significance of miR-4262,NRG1 in non-small cell lung cancer tissues [J]. Journal of International Oncology, 2025, 52(3): 129-135. |
| [5] | Wang Yi, Wang Qiangli, Zhang Jia, Yang Yijin, Wang Sheng. Relationship between the expression of SUCNR1 and YBX1 in tissues of patients with colorectal cancer liver metastases and their clinicopathological characteristics and prognosis [J]. Journal of International Oncology, 2025, 52(3): 152-157. |
| [6] | Han Tao, Jia Peipei, Lu Jing. Predictive value of iRhom1,iRhom2 and TNF-α levels for the prognosis of patients with cervical cancer [J]. Journal of International Oncology, 2025, 52(3): 158-162. |
| [7] | Ye Yongying, Zou Yan, Chen Tianming, Wu Weili. Research progress of clock gene Period family in head and neck squamous cell carcinoma [J]. Journal of International Oncology, 2025, 52(2): 113-118. |
| [8] | Chen Danlei, Deng Junjun, Li Miao. Progress of clinical application of circulating tumor cells in lung cancer [J]. Journal of International Oncology, 2025, 52(2): 119-123. |
| [9] | Ji Haitao, Wang Yanfeng, Liu Yongcheng, Hao Nan. Expression and clinical significance of DHCR7 in gastric cancer based on bioinformatics analysis [J]. Journal of International Oncology, 2025, 52(2): 94-100. |
| [10] | Yipala·Yilihamu , Ma Tao, Wang Yan, Gao Chunjie, Liu Jing, Zhao Ting, Wang Lei. Relationship between body mass indexes and survival prognosis of breast cancer patients with different menopausal status and molecular subtypes [J]. Journal of International Oncology, 2025, 52(12): 745-757. |
| [11] | Liu Pingping, Wang Junyi, Lin Zhiwei, Chen Dachao. Analysis of factors influencing the prognosis of patients with postoperative peritoneal metastasis of gastric cancer [J]. Journal of International Oncology, 2025, 52(12): 764-769. |
| [12] | Song Xueqin, Li Mingying. Research progress of HOXC10 in digestive system neoplasms [J]. Journal of International Oncology, 2025, 52(12): 787-790. |
| [13] | Dai Yujuan, Chen Xianying, Huang Wei, Chen Dachao. Analysis of influencing factors and construction of a risk prediction model for early death in adult glioma [J]. Journal of International Oncology, 2025, 52(10): 609-613. |
| [14] | Lai Ruihe, Sheng Dandan, He Jian, Ding Chongyang, Geng Yuzhi. Prognostic value of 18F-FDG PET/CT metabolic parameters in small cell lung cancer [J]. Journal of International Oncology, 2025, 52(10): 614-620. |
| [15] | Yu Yang, Tang Shimin, Yang Lu, Li Na. Research progress in treatment strategies and prognostic factors for stage pT2-3N0M0 thoracic esophageal squamous cell carcinoma [J]. Journal of International Oncology, 2025, 52(1): 43-47. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||